DE60134249D1 - Pharmazeutisch verwendbare Stärke und deren Herstellungsverfahren - Google Patents

Pharmazeutisch verwendbare Stärke und deren Herstellungsverfahren

Info

Publication number
DE60134249D1
DE60134249D1 DE60134249T DE60134249T DE60134249D1 DE 60134249 D1 DE60134249 D1 DE 60134249D1 DE 60134249 T DE60134249 T DE 60134249T DE 60134249 T DE60134249 T DE 60134249T DE 60134249 D1 DE60134249 D1 DE 60134249D1
Authority
DE
Germany
Prior art keywords
starch
production process
pharmaceutically usable
purified
usable starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60134249T
Other languages
English (en)
Inventor
Nils Ove Gustafsson
Per Berden
Monica Joensson
Timo Laakso
Mats Reslow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacira Pharmaceuticals Inc
Original Assignee
Pacira Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003616A external-priority patent/SE517422C2/sv
Application filed by Pacira Pharmaceuticals Inc filed Critical Pacira Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60134249D1 publication Critical patent/DE60134249D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/04—Extraction or purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60134249T 2000-10-06 2001-10-05 Pharmazeutisch verwendbare Stärke und deren Herstellungsverfahren Expired - Fee Related DE60134249D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0003616A SE517422C2 (sv) 2000-10-06 2000-10-06 Farmaceutiskt acceptabel stärkelse
US26049101P 2001-01-08 2001-01-08
PCT/SE2001/002168 WO2002028909A1 (en) 2000-10-06 2001-10-05 Starch

Publications (1)

Publication Number Publication Date
DE60134249D1 true DE60134249D1 (de) 2008-07-10

Family

ID=26655256

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60134249T Expired - Fee Related DE60134249D1 (de) 2000-10-06 2001-10-05 Pharmazeutisch verwendbare Stärke und deren Herstellungsverfahren
DE60134562T Expired - Fee Related DE60134562D1 (de) 2000-10-06 2001-10-05 Pharmazeutisch verwendbare Stärke und deren Herstellungsverfahren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60134562T Expired - Fee Related DE60134562D1 (de) 2000-10-06 2001-10-05 Pharmazeutisch verwendbare Stärke und deren Herstellungsverfahren

Country Status (8)

Country Link
EP (2) EP1325034B1 (de)
JP (2) JP2004510846A (de)
AT (2) ATE397020T1 (de)
AU (2) AU2001294460A1 (de)
CA (2) CA2424888A1 (de)
DE (2) DE60134249D1 (de)
ES (1) ES2307650T3 (de)
WO (2) WO2002028909A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5100980B2 (ja) * 2005-05-18 2012-12-19 株式会社クラレ 化学物質の精製方法
US8017152B2 (en) 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP1726299A3 (de) 2005-05-27 2007-04-18 StratoSphere Pharma AB Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung
CN114933661B (zh) * 2022-06-27 2022-12-20 上海交通大学 一种三偏磷酸钠交联淀粉的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279658A (en) * 1978-08-16 1981-07-21 Grain Processing Corporation Chemical-mechanical starch conversion
DE4132701A1 (de) * 1991-10-01 1993-04-08 Laevosan Gmbh & Co Kg Verfahren zur herstellung von staerkeabbauprodukten mit einer engen molekulargewichtsverteilung
DE4434877A1 (de) * 1994-09-29 1996-04-04 Fresenius Ag Verfahren zur Herstellung von Stärkeabbauprodukten
CN1126763C (zh) * 1997-08-08 2003-11-05 弗雷泽纽斯股份公司 连续制备水解降解的任选取代淀粉的方法以及用于实施该方法的设备

Also Published As

Publication number Publication date
ATE397020T1 (de) 2008-06-15
JP2004510845A (ja) 2004-04-08
AU2001294457A1 (en) 2002-04-15
JP2004510846A (ja) 2004-04-08
WO2002028908A1 (en) 2002-04-11
EP1325035A1 (de) 2003-07-09
EP1325034A1 (de) 2003-07-09
CA2424888A1 (en) 2002-04-11
ES2307650T3 (es) 2008-12-01
ATE399182T1 (de) 2008-07-15
WO2002028909A1 (en) 2002-04-11
CA2424931A1 (en) 2002-04-11
DE60134562D1 (de) 2008-08-07
EP1325034B1 (de) 2008-06-25
AU2001294460A1 (en) 2002-04-15
EP1325035B1 (de) 2008-05-28

Similar Documents

Publication Publication Date Title
MY122762A (en) Method for producing high-purity sulphuric acid
BR9917289B1 (pt) processo para produção de etanol a partir de cepas clostridium.
DE60220031D1 (de) Strukturelement für eine fahrzeugradaufhängung und verfahren zu deren herstellung
WO2001011428A8 (en) Superconductor articles, compositions, and methods for making same
ATE221078T1 (de) Azithromycinmonohydrat-isopropanol-clathrate und methoden zu deren herstellung
DE60135872D1 (de) Absackbekämpfung bei isorohren, die bei der herstellung von flachglas nach dem schmelzverfahren verwendet werden
ATE326499T1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
EP0854508A3 (de) Herstellungsverfahren für eine Kontaktstruktur
DE60134562D1 (de) Pharmazeutisch verwendbare Stärke und deren Herstellungsverfahren
JP2005503463A5 (de)
BG104590A (en) Method for acetone hydration
WO2002053598A3 (en) Manufacturing process for porous material
IT1318432B1 (it) Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
TR200003302T2 (tr) Anti-astım, anti-alerjik, anti-enflamatuar, bağışıklık düzenleyici ve nöro-koruyucu etkiye sahip yeni 1,2,5-trisübstitüe edilmiş 1,2-dihidroindazol-3-onlar, bunların hazırlanması için işlem ve bunların ilaç olarak kullanımı.
DE69413946D1 (de) Verfahren zur Herstellung von hochreiner 2,6-Naphthalindicarbonsäure
ITVA20020023A1 (it) Prodotti per l'edilizia a base di idrossialchilguaro purificato
DE60320423D1 (de) Verfahren zum herstellen von wasserigen suspensionen von mineralzuschlägen
DE60019663D1 (de) Hochreine anorganische Faser, daraus hergestellte Formkörper und Verfahren zu deren Herstellung
DE60127848D1 (de) T-butoxycarbonylaminoethylamine für die herstellung von pna-monomereinheiten, aminosäurederivate, zwischenprodukte und verfahren zu deren herstellung
AU2002226308A1 (en) Method for producing dnda
CN217599491U (zh) 一种卫生纸生产用收卷装置
DE50001459D1 (de) Beschichtungsverfahren
NO20004636L (no) FremgangsmÕte for separering av difosfindiastereoisomerer
FR2811572B1 (fr) Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee